Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.

Journal

NEJM evidence
ISSN: 2766-5526
Titre abrégé: NEJM Evid
Pays: United States
ID NLM: 9918317485806676

Informations de publication

Date de publication:
Jul 2022
Historique:
medline: 1 7 2022
pubmed: 1 7 2022
entrez: 6 2 2024
Statut: ppublish

Résumé

MDS Molecular International Prognostic Scoring SystemSamples from over 2500 patients with MDS were profiled for gene mutations and used to develop the International Prognostic Scoring System-Molecular (IPSS-M).

Identifiants

DOI: 10.1056/EVIDoa2200008 PMID: 38319256
pubmed: 38319256
doi: 10.1056/EVIDoa2200008
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

EVIDoa2200008

Auteurs

Elsa Bernard (E)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York.

Heinz Tuechler (H)

Peter L Greenberg (PL)

Stanford University Cancer Institute, Stanford, CA.

Robert P Hasserjian (RP)

Department of Pathology, Massachusetts General Hospital, Boston.

Juan E Arango Ossa (JE)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York.

Yasuhito Nannya (Y)

Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Division of Hematopoietic Disease Control, Institute of Medical Science, University of Tokyo, Tokyo.

Sean M Devlin (SM)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York.

Maria Creignou (M)

Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm.

Philippe Pinel (P)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York.

Lily Monnier (L)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York.

Gunes Gundem (G)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York.

Juan S Medina-Martinez (JS)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York.

Dylan Domenico (D)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York.

Martin Jädersten (M)

Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm.

Ulrich Germing (U)

Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany.

Guillermo Sanz (G)

Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
CIBERONC, Instituto de Salud Carlos III, Madrid.
Health Research Institute La Fe, Valencia, Spain.

Arjan A van de Loosdrecht (AA)

Department of Hematology, Amsterdam University Medical Center, Vrije University Medical Center, Amsterdam.

Olivier Kosmider (O)

Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin and Université de Paris, Université Paris Descartes, Paris.

Matilde Y Follo (MY)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Felicitas Thol (F)

Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.

Lurdes Zamora (L)

Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Barcelona.

Ronald F Pinheiro (RF)

Drug Research and Development Center, Federal University of Ceara, Ceara, Brazil.

Andrea Pellagatti (A)

Radcliffe Department of Medicine, Oxford BRC Haematology Theme, University of Oxford, Oxford, United Kingdom.

Harold K Elias (HK)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.

Detlef Haase (D)

Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany.

Christina Ganster (C)

Clinics of Hematology and Medical Oncology, University Medical Center, Göttingen, Germany.

Lionel Ades (L)

Department of Hematology, Hôpital St Louis, and Paris University, Paris.

Magnus Tobiasson (M)

Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm.

Laura Palomo (L)

Myelodysplastic Syndromes Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Barcelona.

Matteo Giovanni Della Porta (MG)

Cancer Center, Humanitas Research Hospital & Humanitas University, Milan.

Akifumi Takaori-Kondo (A)

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Takayuki Ishikawa (T)

Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.

Shigeru Chiba (S)

Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Senji Kasahara (S)

Department of Hematology, Gifu Municipal Hospital, Gifu, Japan.

Yasushi Miyazaki (Y)

Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.

Agnes Viale (A)

Integrated Genomics Operation, Memorial Sloan Kettering Cancer Center, New York.

Kety Huberman (K)

Integrated Genomics Operation, Memorial Sloan Kettering Cancer Center, New York.

Pierre Fenaux (P)

Department of Hematology, Hôpital St Louis, and Paris University, Paris.

Monika Belickova (M)

Department of Genomics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.

Michael R Savona (MR)

Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville.

Virginia M Klimek (VM)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.

Fabio P S Santos (FPS)

Oncology-Hematology Center, Hospital Israelita Albert Einstein, São Paulo.

Jacqueline Boultwood (J)

Radcliffe Department of Medicine, Oxford BRC Haematology Theme, University of Oxford, Oxford, United Kingdom.

Ioannis Kotsianidis (I)

Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece.

Valeria Santini (V)

Myelodysplastic syndromes Unit, Department of Experimental and Clinical Medicine, Hematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy.

Francesc Solé (F)

Myelodysplastic Syndromes Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Barcelona.

Uwe Platzbecker (U)

Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University of Leipzig, Leipzig, Germany.

Michael Heuser (M)

Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.

Peter Valent (P)

Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna.
Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna.

Kazuma Ohyashiki (K)

Tokyo Medical University, Tokyo.

Carlo Finelli (C)

Institute of Hematology "Seràgnoli," Istituti di Ricovero e Cura a Carattere Scientifico Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Maria Teresa Voso (MT)

Myelodysplastic syndromes Cooperative Group Gruppo Laziale Mielodisplasie (GROM-L), Department of Biomedicine and Prevention, Tor Vergata University, Rome.

Lee-Yung Shih (LY)

Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taiwan.

Michaela Fontenay (M)

Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin and Université de Paris, Université Paris Descartes, Paris.

Joop H Jansen (JH)

Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.

José Cervera (J)

Department of Hematology and Genetics Unit, University Hospital La Fe, Valencia, Spain.

Norbert Gattermann (N)

Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany.

Benjamin L Ebert (BL)

Department of Medical Oncology, Howard Hughes Medical Institute, Dana-Farber Cancer Center, Boston.

Rafael Bejar (R)

University of California San Diego Moores Cancer Center, La Jolla, CA.

Luca Malcovati (L)

Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy.

Mario Cazzola (M)

Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy.

Seishi Ogawa (S)

Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.
Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm.

Eva Hellström-Lindberg (E)

Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm.

Elli Papaemmanuil (E)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York.

Classifications MeSH